October Pharma’s BoD agreed to a cash dividend distribution of EGP 36 million or EGP 6 per share for 2021’s earnings. The board also proposed distributing 2 bonus shares per share, totaling EGP 120 million of retained earnings.
The company reported a net profit of EGP 119.8 million in 2021, up 36% YoY.
The company’s revenues last year amounted to EGP 655 million, compared to EGP 543.3 million in 2020.